Gut Microbes

Article	Citations
Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	309
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	284
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	276
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	229
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	228
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	177
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	170
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	163
Intestinal bacteria and colorectal cancer: etiology and treatment	160
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	145
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	145
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	142
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	140
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	129
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	123
Gut microbiota and tuberculosis infection: interaction and therapeutic potential	121
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	121
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation	119
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	118
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	108
Effect of diet on the evolution of gut commensal bacteria	106
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	105
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	99
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	97
Modeling spatial interaction networks of the gut microbiota	97

Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	97
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	96
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	94
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	93
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	92
Metabolic modeling links gut microbiota to metabolic markers of Parkinson’s disease	92
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	90
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	88
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	87
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	87
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	87
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	86
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	85
The Fe-S cluster biosynthesis in Enterococcus faecium is essential for anaerobic growth and gastrointestinal colonization	84
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	84
mbSparse: an autoencoder-based imputation method to address sparsity in microbiome data	83
The emerging role of the gut microbiota in vaccination responses	83
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	83
In vivo systematic analysis of microbiota-prebiotic crosstalk reveals a synbiotic that effectively ameliorates DSS-induced colitis in mice	82
Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk	81
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice	81
Engineered bacteria as an orally administered anti-viral treatment and immunization system	80
Akkermansia in the gastrointestinal tract as a modifier of human health	80
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	80
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	79
Proton pump inhibitors are not associated with an increased risk of Clostridioides difficile infection: a systematic review and meta-analysis of randomized controlled tr	78
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	78
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	76
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	75
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	74
Comparison of gnotobiotic communities reveals milk-adapted metabolic functions and unexpected amino acid metabolism by the pre-weaning microbiome	74
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	73
MS-20 enhances the gut microbiota-associated antitumor effects of anti-PD1 antibody	72
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	72
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	70
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	69
Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC	67
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	67
Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation	66
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	66
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	66
Gut microbiota-mediated conversion of mangiferin to norathyriol alters short chain fatty acid and urate metabolism	65
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	65
Therapeutic potential of Clostridium butyricum anticancer effects in colorectal cancer	65
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy	65
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	65
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	65
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	64
Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection	63
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	63

Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	63
Resveratrol amplifies the anti-tumor effect of α-PD-1 by altering the intestinal microbiome and PGD2 content	62
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	62
Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design	62
Entamoeba muris mitigates metabolic consequences of high-fat diet in mice	61
Intestinal deguelin drives resistance to acetaminophen-induced hepatotoxicity in female mice	60
Single cell viral tagging of Faecalibacterium prausnitzii reveals rare bacteriophages omitted by other techniques	60
Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide	60
CRIg+ macrophages deficiency enhanced inflammation damage in IBD due to gut extracellular vesicles containing microbial DNA	59
CobB-mediated deacetylation of the chaperone CesA regulates Escherichia coli O157:H7 virulence	59
Quorum sensing modulates bacterial virulence and colonization dynamics of the gastrointestinal pathogen Citrobacter rodentium	59
Alterations in mucosa branched N -glycans lead to dysbiosis and downregulation of ILC3: a key driver of intestinal inflammation	59
The multifaceted virulence of adherent-invasive Escherichia coli	59
A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bi	58
Secretory IgA dysfunction underlies poor prognosis in Fusobacterium -infected colorectal cancer	58
Comprehensive assessment of machine learning methods for diagnosing gastrointestinal diseases through whole metagenome sequencing data	58
Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis	58
Metagenomic analysis reveals distinct patterns of gut microbiota features with diversified functions in C. difficile infection (CDI), asymptomatic carriage and non-CDI d	57
Bacillus coagulans ameliorates inflammatory bone loss in post-menopausal osteoporosis via modulating the “Gut-Immune-Bone” axis	57
Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights	57
Fungal feelings in the irritable bowel syndrome: the intestinal mycobiome and abdominal pain	57
Integrative analysis with microbial modelling and machine learning uncovers potential alleviators for ulcerative colitis	56
The transplantation of the gut microbiome of fat-1 mice protects against colonic mucus layer disruption and endoplasmic reticulum stress induced by high fat diet	56
Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment	56
Sex-specific post-inflammatory dysbiosis mediates chronic visceral pain in colitis	56
Clostridioides difficile binary toxin CDT induces biofilm-like persisting microcolonies	56
Intratumoral microbiome is associated with gastric cancer prognosis and therapy efficacy	55
Why are so many enteric pathogen infections asymptomatic? Pathogen and gut microbiome characteristics associated with diarrhea symptoms and carriage of diarrheagenic E. coli	55
Role of gut microbes in acute lung injury/acute respiratory distress syndrome	54
The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation	54
The human gut microbiome and aging	54
Gut microbe–host interactions in post-COVID syndrome: a debilitating or restorative partnership?	54
Akkermansia muciniphila upregulates genes involved in maintaining the intestinal barrier function via ADP-heptose-dependent activation of the ALPK1/TIFA pathway	54
Prebiotic oligofructose protects against high-fat diet-induced obesity by changing the gut microbiota, intestinal mucus production, glycosylation and secretion	53
Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward	53
Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan	53
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver disease	52
Pro-mutagenic effects of the gut microbiota in a Lynch syndrome mouse model	52
Epidemiology of bacterial biofilms on polyps and normal tissues in a screening colonoscopy cohort	52
Microbiome’s role in musculoskeletal health through the gut-bone axis insights	51
Staphylococcus haemolyticus is a reservoir of antibiotic resistance genes in the preterm infant gut	51
PMA1-containing extracellular vesicles of Candida albicans triggers immune responses and colitis progression	51
Stevioside mitigates metabolic dysregulation in offspring induced by maternal high-fat diet: the role of gut microbiota-driven thermogenesis	51
Targeting gut microbiota in aging-related cardiovascular dysfunction: focus on the mechanisms	50
Antibiotic-induced gut dysbiosis elicits gut-brain axis relevant multi-omic signatures and behavioral and neuroendocrine changes in a nonhuman primate model	50
Salmonella utilizes L-arabinose to silence virulence gene expression for accelerated pathogen growth within the host	50
Probiotic-induced enrichment of Adlercreutzia equolifaciens increases gut microbiome wellness index and maps to lower host blood glucose levels	50
From a hunger-regulating hormone to an antimicrobial peptide: gastrointestinal derived circulating endocrine hormone-peptide YY exerts exocrine antimicrobial effects against selective gut microbiota	50
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease	50
Atovaquone-proguanil and reduced digestive cancer risk: a Toxoplasma gondii connection	50
Human milk oligosaccharides combine with Bifidobacterium longum to form the “golden shield” of the infant intestine: metabolic strategies, health effects, and mechanisms	49
Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella -induced arthritis	49
Stool multi-omics for the study of host–microbe interactions in inflammatory bowel disease	49
Long-term yogurt intake and colorectal cancer incidence subclassified by Bifidobacterium abundance in tumor	48
Lactic acid bacteria and bifidobacteria deliberately introduced into the agro-food chain do not significantly increase the antimicrobial resistance gene pool	48
Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota	48
A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma	48
The fecal microbiota of patients with primary biliary cholangitis (PBC) causes PBC-like liver lesions in mice and exacerbates liver damage in a mouse model of PBC	48
Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases	47
Infant gut microbiota restoration: state of the art	47
Membrane protective role of autophagic machinery during infection of epithelial cells by Candida albicans	47
The use of probiotics and prebiotics in decolonizing pathogenic bacteria from the gut; a systematic review and meta-analysis of clinical outcomes	47
Stability in fecal metabolites amid a diverse gut microbiome composition: a one-month longitudinal study of variability in healthy individuals	47
Gut microbiome at the crossroad of genetic variants and behavior disorders	47
Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma	47
Enterohemorrhagic Escherichia coli responds to gut microbiota metabolites by altering metabolism and activating stress responses	47
Fusobacterium nucleatum -driven CX3CR1 + PD-L1 + phagocytes route to tumor tissues and reshape tumor microenvir	46
Exploring substrate–microbe interactions: a metabiotic approach toward developing targeted synbiotic compositions	46
Butyrate acts through HDAC inhibition to enhance aryl hydrocarbon receptor activation by gut microbiota-derived ligands	46
The duodenal mucosa associated microbiome, visceral sensory function, immune activation and psychological comorbidities in functional gastrointestinal disorders with and without self-reported non-celi	45
Multi-omics analysis revealing the interplay between gut microbiome and the host following opioid use	45
Genome-wide multi-omics analysis reveals the nutrient-dependent metabolic features of mucin-degrading gut bacteria	44
High variation across E. coli hybrid isolates identified in metabolism-related biological pathways co-expressed with virulent genes	44
PUFAs add fuel to Crohn’s disease-associated AIEC-induced enteritis by exacerbating intestinal epithelial lipid peroxidation	44
Gut microbiota alterations induced by Roux-en-Y gastric bypass result in glucose-lowering by enhancing intestinal glucose excretion	44
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data	44
Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice	44
Oral pathobiont Klebsiella chaperon usher pili provide site-specific adaptation for the inflamed gut mucosa	43
Using a human colonoid-derived monolayer to study bacteriophage translocation	43
Evaluation of gut microbiota predictive potential associated with phenotypic characteristics to identify multifactorial diseases	43

Magnetic chitin beads (MCB) coated with Vibrio cholerae reveals transcriptome dynamics in adult mice with a complex gut microbiota	43
Interaction of the Gut-Liver-Brain Axis and the sterolbiome with sexual dysfunction in patients with cirrhosis	43
Transfer of microbiota from lean donors in combination with prebiotics prevents excessive weight gain and improves gut-brain vagal signaling in obese rats	43
Preexisting antibodies targeting SARS-CoV-2 S2 cross-react with commensal gut bacteria and impact COVID-19 vaccine induced immunity	42
Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation	42
Parvimonas micra , an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes	42
Exploring the etiology of colitis: insights from gut microbiota research	42
End-to-end donor screening and manufacturing controls: complementary quality-based strategies to minimize patient risk for donor-derived microbiome therapeutics	42
Fabry disease – a multisystemic disease with gastrointestinal manifestations	41
The interplay between PCOS pathology and diet on gut microbiota in a mouse model	41
Gut microbiota-driven metabolic alterations reveal gut–brain communication in Alzheimer’s disease model mice	41
Akkermansia muciniphila : a deworming partner independent of type 2 immunity	41
Gut bacterial aromatic amine production: aromatic amino acid decarboxylase and its effects on peripheral serotonin production	41
Dietary iron modulates gut microbiota and induces SLPI secretion to promote colorectal tumorigenesis	41
Mouse strain-specific responses along the gut-brain axis upon fecal microbiota transplantation from children with autism	41
Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection	41
Single-cell microbiota phenotyping reveals distinct disease and therapy-associated signatures in Crohn’s disease	40
The role and mechanism of gut-lung axis mediated bidirectional communication in the occurrence and development of chronic obstructive pulmonary disease	40
IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation	40
The Helicobacter pylori cag pathogenicity island as a determinant of gastric cancer risk	40
Sweet, bloody consumption – what we eat and how it affects vascular ageing, the BBB and kidney health in CKD	40
Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis	40
Quinic acid alleviates high-fat diet-induced neuroinflammation by inhibiting DR3/IKK/NF-κB signaling via gut microbial tryptophan metabolites	39
Changes in intestinal permeability and gut microbiota following diet-induced weight loss in patients with metabolic dysfunction-associated steatohepatitis and liver fibrosis	39
Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation	39
Alterations in gut virome are associated with cognitive function and minimal hepatic encephalopathy cross-sectionally and longitudinally in cirrhosis	39
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response	39
ZntA maintains zinc and cadmium homeostasis and promotes oxidative stress resistance and virulence in Vibrio parahaemolyticus	39
The impact of gut microbial short-chain fatty acids on colorectal cancer development and prevention	39
Impact of intensive lifestyle intervention on gut microbiota composition in type 2 diabetes: a post-hoc analysis of a randomized clinical trial	39
Integrated analysis of gut metabolome, microbiome, and brain function reveal the role of gut-brain axis in longevity	39
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin	39
The transcriptional regulation of the horizontally acquired iron uptake system, yersiniabactin and its contribution to oxidative stress tolerance and pathogenicity of globally emerging	38
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma	38
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis	38
Breastfeeding and the major fermentation metabolite lactate determine occurrence of Peptostreptococcaceae in infant feces	38
M28 family peptidase derived from Peribacillus frigoritolerans initiates trained immunity to prevent MRSA via the complosome-phosphatidylcholine axis	38
Advancing therapeutics for recurrent clostridioides difficile infections: an overview of vowst’s FDA approval and implications	37
Gut microbiome in healthy aging versus those associated with frailty	37
Psyllium fiber protects mice against western diet-induced metabolic syndrome via the gut microbiota-dependent mechanism	37
Long- and short-term effects of fecal microbiota transplantation on antibiotic resistance genes: results from a randomized placebo-controlled trial	37
Fucose promotes intestinal stem cell-mediated intestinal epithelial development through promoting Akkermansia -related propanoate metabolism	37
Morphine mediated neutrophil infiltration in intestinal tissue play essential role in histological damage and microbial dysbiosis	37
Dietary S. maltophilia induces supersized lipid droplets by enhancing lipogenesis and ER-LD contacts in C. elegans	37
Spatio-temporal dynamics of the human small intestinal microbiome and its response to a synbiotic	37
Interleukin-1β secretion induced by mucosa-associated gut commensal bacteria promotes intestinal barrier repair	37
Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions	37
Gene content, phage cycle regulation model and prophage inactivation disclosed by prophage genomics in the Helicobacter pylori Genome Project	37
Effects of postbiotics on chronic diarrhea in young adults: a randomized, double-blind, placebo-controlled crossover trial assessing clinical symptoms, gut microbiota, and metabolite profiles	36
Neonatal necrotizing enterocolitis: Clostridium butyricum and Clostridium neonatale fermentation metabolism and enteropathogenicity	36
Better together– Salmonella biofilm-associated antibiotic resistance	36
Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis	36
A Mediterranean-like fat blend protects against the development of severe colitis in the mucin-2 deficient murine model	36
Gut microbiota-derived 4-hydroxyphenylacetic acid from resveratrol supplementation prevents obesity through SIRT1 signaling activation	36
Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism alteration regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease	36
Primers matter: Influence of the primer selection on human fungal detection using high throughput sequencing	35
Reexamining the role of Fusobacterium nucleatum subspecies in clinical and experimental studies	35
Dietary fiber for the prevention of childhood obesity: a focus on the involvement of the gut microbiota	35
The hidden base of the iceberg: gut peptidoglycome dynamics is foundational to its influence on the host	35
B. longum CKD1 enhances the efficacy of anti-diabetic medicines through upregulation of IL- 22 response in type 2 diabetic mice	34
Diet standardization reduces intra-individual microbiome variation	34
Alcaligenes faecalis promotes colitis to colorectal cancer transition through IgA+ B cell suppression and vinculin acetylation	34
Fecal microbiota transplantation derived from mild cognitive impairment individuals impairs cerebral glucose uptake and cognitive function in wild-type mice: Bacteroidetes	34
DSS treatment does not affect murine colonic microbiota in absence of the host	34
Unveiling the hidden players: exploring the role of gut mycobiome in cancer development and treatment dynamics	34
Metaproteomics reveals age-specific alterations of gut microbiome in hamsters with SARS-CoV-2 infection	34
Diet-induced shifts in the gut microbiota influence anastomotic healing in a murine model of colonic surgery	34
Maternal-infant probiotic transmission mitigates early-life stress-induced autism in mice	34
Viral metagenomics of the gut virome of diarrheal children with Rotavirus A infection	34
Comparing early life nutritional sources and human milk feeding practices: personalized and dynamic nutrition supports infant gut microbiome development and immune system maturation	33
Actively replicating gut bacteria identified by 5-ethynyl-2’-deoxyuridine (EdU) click chemistry and cell sorting	33
Preterm infants at low risk for early-onset sepsis differ in early fecal microbiome assembly	33
The landscape in the gut microbiome of long-lived families reveals new insights on longevity and aging – relevant neural and immune function	33
Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction	33
Bacteroides fragilis alleviates necrotizing enterocolitis through restoring bile acid metabolism balance using bile salt hydrolase and inhibiting FXR-NLRP3 signaling pathway	33
The early life exposome and autism risk: a role for the maternal microbiome?	33
Lactic acid bacteria derived extracellular vesicles: emerging bioactive nanoparticles in modulating host health	33
Lactobacillus rhamnosus GG ameliorates osteoporosis in ovariectomized rats by regulating the Th17/Treg balance and gut microbiota structure	33
The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia	33
Genetic variation in gut microbe as a key regulator of host social behavior in C. elegans	32
Intestinal microbiota modulates pancreatic carcinogenesis through intratumoral natural killer cells	32
Parity modulates impact of BMI and gestational weight gain on gut microbiota in human pregnancy	32
Metagenomic source tracking after microbiota transplant therapy	32
The human gut serves as a reservoir of hypervirulent Klebsiella pneumoniae	32
Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients	32
The gut microbiota: an emerging modulator of drug resistance in hepatocellular carcinoma	32
The development of live biotherapeutics against Clostridioides difficile infection towards reconstituting gut microbiota	32
Bacterial flagellin is a dominant, stable innate immune activator in the gastrointestinal contents of mice and rats	32
Children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorder share distinct microbiota compositions	31
Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury	31
Methodological challenges in neonatal microbiome research	31
New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation	31
Muropeptides and muropeptide transporters impact on host immune response	31
Hydrogen peroxide in breast milk is crucial for gut microbiota formation and myelin development in neonatal mice	31
How longitudinal data can contribute to our understanding of host genetic effects on the gut microbiome	31